PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics granted inducement awards to 18 new employees on June 11, 2026, consisting of non-statutory stock options and restricted stock units. The grants include options to purchase 10,050 shares of common stock and 11,870 RSUs, with the options priced at $74.71 per share, equal to the closing price on the grant date.
Key figures
- New hires
- 18
- Rsus count
- 11870
- Exercise price
- 74.71
- Options shares
- 10050
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.